RBBN(RBBN)
RBBN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $837M | $883M |
| Low | $836M | $878M |
| High | $839M | $886M |
| EBITDA Avg | $239M | $252M |
| Low | $239M | $251M |
| High | $239M | $253M |
| EBIT Avg | $200M | $211M |
| Low | $199M | $210M |
| High | $200M | $211M |
| Net Income Avg | $23M | $35M |
| Low | $20M | $35M |
| High | $26M | $35M |
| EPS Avg | $0.13 | $0.20 |
| Low | $0.11 | $0.19 |
| High | $0.15 | $0.20 |
| Analysts (Rev / EPS) | 4 / 2 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $225M | $260M | $196M | $213M | $227M | $248M |
| Low | $220M | $254M | $192M | $208M | $222M | $242M |
| High | $229M | $267M | $202M | $219M | $234M | $255M |
| EBITDA Avg | $64M | $74M | $56M | $61M | $65M | $71M |
| Low | $63M | $72M | $55M | $59M | $63M | $69M |
| High | $65M | $76M | $58M | $62M | $67M | $73M |
| EBIT Avg | $54M | $62M | $47M | $51M | $54M | $59M |
| Low | $53M | $61M | $46M | $50M | $53M | $58M |
| High | $55M | $64M | $48M | $52M | $56M | $61M |
| Net Income Avg | $10M | $23M | $1M | $5M | $11M | $18M |
| Low | $10M | $22M | $1M | $5M | $11M | $17M |
| High | $11M | $24M | $1M | $5M | $12M | $18M |
| EPS Avg | $0.06 | $0.13 | $0.01 | $0.03 | $0.07 | $0.10 |
| Low | $0.06 | $0.13 | $0.01 | $0.03 | $0.06 | $0.10 |
| High | $0.06 | $0.14 | $0.01 | $0.03 | $0.07 | $0.10 |
| Analysts (Rev / EPS) | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |